Avricore Health Inc. Files June 2025 6-K Report
Ticker: AVCRF · Form: 6-K · Filed: Jul 11, 2025 · CIK: 1355736
| Field | Detail |
|---|---|
| Company | Avricore Health INC. (AVCRF) |
| Form Type | 6-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, corporate-history
TL;DR
AVRICORE HEALTH (AVRX) filed its June 6-K, confirming 40-F annual report status.
AI Summary
Avricore Health Inc. filed a Form 6-K for the month of June 2025, reporting as a foreign private issuer. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceuticals Inc., and ALDA Pharmaceuticals Corp., is incorporated in A1 and has its principal executive offices at 1120-789 West Pender St, Vancouver, BC, V6C 1H2. The filing indicates the company is submitting its annual reports under Form 40-F.
Why It Matters
This filing provides routine updates for Avricore Health Inc. as a foreign private issuer, informing investors about their reporting status and corporate history.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Avricore Health Inc. (company) — Registrant
- Vanc Pharmaceuticals Inc. (company) — Former company name
- NUVA Pharmaceuticals Inc. (company) — Former company name
- ALDA Pharmaceuticals Corp. (company) — Former company name
- 20250630 (date) — Conformed period of report
- 20250711 (date) — Filed as of date
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What is Avricore Health Inc.'s SEC file number?
Avricore Health Inc.'s SEC file number is 000-51848.
Which form does Avricore Health Inc. use for its annual reports?
Avricore Health Inc. indicates it files its annual reports under cover of Form 40-F.
What is the principal executive office address for Avricore Health Inc.?
The principal executive office address is 1120-789 West Pender St, Vancouver, BC, V6C 1H2.
What were some of Avricore Health Inc.'s former company names?
Avricore Health Inc. was formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceuticals Inc., and ALDA Pharmaceuticals Corp.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 11, 2025 regarding Avricore Health Inc. (AVCRF).